From the USAToday.com comes a story about Menssana Research Inc., a Fort Lee, New Jersey based company, that is developing methods to detect cancers and heart transplant rejection based on patient’s breath. According to the company, the Breathscanner 1.0, its flagship product, has the following features:
- Analyzes the volatile organic compounds (VOCs) in breath
- Identifies markers of oxidative stress and disease
- Mobile gas chromatography and mass spectroscopy
- Picomolar sensitivity (parts per trillion)
- Results in minutes
- Fits on a desk or a cart
The story at USAToday.com…
Menssana Research website…
FLASHBACK: Electronic Nose Shows Promise for Lung CA Detection.
